| Dr Yu Sung Kim, MD | |
|
201 N Washington St, Falls Church, VA 22046-4518 | |
| (703) 237-4000 | |
| Not Available |
| Full Name | Dr Yu Sung Kim |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 201 N Washington St, Falls Church, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053568436 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Capital Hospice | Falls church, VA | Hospice |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
A project at the university of Leeds aiming to improve the investigation and management of patients with suspected angina has received a grant of almost £150,000 from national charity Heart Research UK.
A large, multi-institutional research team involved in the NIH Epigenome Roadmap Project has published a sweeping analysis in the current issue of the journal Cell of how genes are turned on and off to direct early human development.
The case against the Affordable Care Act rests on the premise that the free market can better provide health insurance to the nation's 54 million uninsured than a government program can. But what does it mean if many of the same people who oppose Obamacare also object to the cost of covering more people through the market? A telephone survey by Bankrate.com asked 3,496 people how they would react if a business tacked on an extra 25 cents to every bill to help cover the cost of health insurance for its employees. Among Democrats, 70 percent said they would approve.
GlaxoSmithKline PLC (GSK) and Amicus Therapeutics today announced a definitive agreement to develop and commercialize Amigal™ (migalastat HCl), currently in Phase 3 for the treatment of Fabry disease, a rare inherited disorder. Under the terms of the agreement, GSK will receive an exclusive worldwide license to develop, manufacture and commercialize migalastat HCl.
STERIS Corporation today announced it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the terms of a consent decree regarding its SYSTEM 1® liquid chemical sterilization system. Included in the agreement is a Transition Plan with a Rebate Program for current SYSTEM 1 Customers in the U.S. The consent decree is subject to approval by the U.S. District Court for the Northern District of Ohio.
› Verified 8 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
A project at the university of Leeds aiming to improve the investigation and management of patients with suspected angina has received a grant of almost £150,000 from national charity Heart Research UK.
A large, multi-institutional research team involved in the NIH Epigenome Roadmap Project has published a sweeping analysis in the current issue of the journal Cell of how genes are turned on and off to direct early human development.
The case against the Affordable Care Act rests on the premise that the free market can better provide health insurance to the nation's 54 million uninsured than a government program can. But what does it mean if many of the same people who oppose Obamacare also object to the cost of covering more people through the market? A telephone survey by Bankrate.com asked 3,496 people how they would react if a business tacked on an extra 25 cents to every bill to help cover the cost of health insurance for its employees. Among Democrats, 70 percent said they would approve.
GlaxoSmithKline PLC (GSK) and Amicus Therapeutics today announced a definitive agreement to develop and commercialize Amigal™ (migalastat HCl), currently in Phase 3 for the treatment of Fabry disease, a rare inherited disorder. Under the terms of the agreement, GSK will receive an exclusive worldwide license to develop, manufacture and commercialize migalastat HCl.
STERIS Corporation today announced it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the terms of a consent decree regarding its SYSTEM 1® liquid chemical sterilization system. Included in the agreement is a Transition Plan with a Rebate Program for current SYSTEM 1 Customers in the U.S. The consent decree is subject to approval by the U.S. District Court for the Northern District of Ohio.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yu Sung Kim, MD 2101 E Jefferson St, Kaiser Permanente Medicare Enrollment, Rockville, MD 20852-4908 Ph: (301) 816-2424 | Dr Yu Sung Kim, MD 201 N Washington St, Falls Church, VA 22046-4518 Ph: (703) 237-4000 |
News Archive
A project at the university of Leeds aiming to improve the investigation and management of patients with suspected angina has received a grant of almost £150,000 from national charity Heart Research UK.
A large, multi-institutional research team involved in the NIH Epigenome Roadmap Project has published a sweeping analysis in the current issue of the journal Cell of how genes are turned on and off to direct early human development.
The case against the Affordable Care Act rests on the premise that the free market can better provide health insurance to the nation's 54 million uninsured than a government program can. But what does it mean if many of the same people who oppose Obamacare also object to the cost of covering more people through the market? A telephone survey by Bankrate.com asked 3,496 people how they would react if a business tacked on an extra 25 cents to every bill to help cover the cost of health insurance for its employees. Among Democrats, 70 percent said they would approve.
GlaxoSmithKline PLC (GSK) and Amicus Therapeutics today announced a definitive agreement to develop and commercialize Amigal™ (migalastat HCl), currently in Phase 3 for the treatment of Fabry disease, a rare inherited disorder. Under the terms of the agreement, GSK will receive an exclusive worldwide license to develop, manufacture and commercialize migalastat HCl.
STERIS Corporation today announced it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the terms of a consent decree regarding its SYSTEM 1® liquid chemical sterilization system. Included in the agreement is a Transition Plan with a Rebate Program for current SYSTEM 1 Customers in the U.S. The consent decree is subject to approval by the U.S. District Court for the Northern District of Ohio.
› Verified 8 days ago
Amita Rajani, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3300 Gallows Road Inova Fairfax Medical Campus, Department Of Medicine, Npt-2, Falls Church, VA 22042 Phone: 703-776-7780 | |
Dr. Mary Beck O'donnell, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2960 Sleepy Hollow Rd, Falls Church, VA 22044 Phone: 703-536-2000 Fax: 703-536-4256 | |
Lindsey A. Cilia, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 Telestar Ct Ste 200, Falls Church, VA 22042 Phone: 703-573-3494 Fax: 703-573-5353 | |
Chin Hee Kim, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd Dept Of, Falls Church, VA 22042 Phone: 703-776-3582 | |
Candyce Heather Greene, MD, MPH, MSW Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Megan Elizabeth Terek, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Hazim El-haddad, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 Telestar Ct Ste 200, Falls Church, VA 22042 Phone: 703-573-3494 Fax: 703-573-5353 |